Torsten Dreier

This inventor holds 27 USPTO granted patents and 13 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Therapeutic Antibodies. Top assignees: Argenx Bv, Argen-X N.v., Argenx Bvba. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Torsten Dreier. Retrieved from https://idiyas.com/inventor/torsten-dreier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 162(Granted Patents)

Location History:

Sint Martens Letem, BE (2013 - 2016)
Breda, NL (2018)
Sint Martens Latem, BE (2013 - 2022)
Sint Martems Latem, BE (2014 - 2022)
Ghent, BE (2023)

Company Filing History:

The University of Texas System

patents

5. 2 out of 100

Universitè Catholique De Louvain

patents

6. 1 out of 1

Université Catholique De Louvian

patent

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

FcRn Antagonists

IL-6 Binding Molecules

CD70 Antibodies

GARP-TGF-beta 1

Anti c-Met Antibodies

Chimeric Antigens

Nucleic Acids

Antigen Binding Polypeptides

Therapeutic Compositions

Immune Thrombocytopenia

Generalized Myasthenia Gravis

Humanized Antibodies

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240875 - Use of FCRN antagonists for treatment of generalized myasthenia gravis (2025-03-04),

2. 12202900 - Compositions and methods for treating immune thrombocytopenia (2025-01-21),

3. 11827701 - IL-6 binding molecules (2023-11-28),

4. 11505585 - FcRn antagonists and methods of use (2022-11-22),

5. 11434298 - Antibodies to CD70 (2022-09-06),

6. 11117959 - IL-6 binding molecules (2021-09-14),

7. 11072665 - Antibodies to CD70 (2021-07-27),

8. 10875914 - Nucleic acids encoding GARP-TGF-beta 1 antibodies (2020-12-29),

9. 10793627 - GARP-TGF-β 1 IGG antibodies (2020-10-06),

10. 10676535 - Anti c-Met antibodies (2020-06-09),

11. 10479829 - GARP-TGF-beta 1 antibodies (2019-11-19),

12. 10316073 - FCRN antagonists and methods of use (2019-06-11),

13. 10183995 - IL-6 binding molecules (2019-01-22),

14. 9926364 - Chimeric human-llama antigens and methods of use (2018-03-27),

15. 9884917 - Anti c-Met antibodies (2018-02-06),

Title: Torsten Dreier - Innovative Inventor from Sint-Martens-Latem, BE

Introduction: Torsten Dreier is a renowned inventor hailing from Sint-Martens-Latem, Belgium, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Torsten Dreier holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Torsten Dreier has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide. His innovative spirit and dedication to excellence have earned him recognition as a pioneer in the field of invention.

Collaborations: Throughout his career, Torsten Dreier has collaborated with top engineers, scientists, and inventors to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development of numerous groundbreaking innovations.

Conclusion: Torsten Dreier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs. His impact on the world of technology is truly remarkable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.